Robert Harington talks to Carsten Buhr, CEO of De Gruyter Brill, in this series of perspectives from some of Publishing’s leaders across the non-profit and for-profit sectors of our industry.
In Asia, open access adoption is accelerating, yet the legal and structural underpinnings of this openness remain fragile, with significant licensing and copyright confusion.
Robert Harington talks to Melissa Junior, Executive Publisher at The American Society for Microbiology, in this series of perspectives from some of Publishing’s leaders across the non-profit and for-profit sectors of our industry.
An AAAS survey reveals authors’ concerns and confusion regarding open licensing of their work.
Robert Harington digs into the world of preprints. He uses the field of mathematics to explore how an inclusive view of preprints and published articles leads to a research ecosystem that is greater than the sum of the parts.
Christos Petrou examines the rapid growth in publication volume coming from China, and how that is impacting the publishing industry.
This post explores why many Middle East- and North Africa-based journals remain underrepresented in global indexing databases, how this affects both local and international knowledge flows, and what alternative pathways can bring the region into fuller view.
Robert Harington talks to Matt Kissner, CEO of Wiley, in this series of perspectives from some of Publishing’s leaders across the non-profit and for-profit sectors of our industry.
Librarian attendees reflect on their experiences at SSP’s Annual Meeting in Baltimore.
AI Bots are overwhelming server capacity and impeding access to collections. How big is the problem and what solutions exist?
Legal scholar and research librarian Latia Ward explains why changes to ADA Title II matter to all libraries — and offers recommendations.
How does the Directory of Open Access Books navigate challenges to instill trust and transparency. Part 2 of 2.
How does the Directory of Open Access Books navigate challenges to instill trust and transparency. Part 1 of 2.
Vannevar Bush’s “The Endless Frontier” served as both blueprint and symbol of the American research enterprise. His writings are worth re-examination, as the country grapples (again) with the relationship between science and the American public.
The NIH has answered the lingering questions about the future of the Nelson Memo. Not only is it still in effect, it’s being accelerated by six months. We asked the Chefs for their thoughts.